Search results
Results from the WOW.Com Content Network
The historical application of biotechnology throughout time is provided below in chronological order. These discoveries, inventions and modifications are evidence of the application of biotechnology since before the common era and describe notable events in the research, development and regulation of biotechnology.
Each new scientific advance became a media event designed to capture public support, and by the 1980s, biotechnology grew into a promising real industry. In 1988, only five proteins from genetically engineered cells had been approved as drugs by the United States Food and Drug Administration (FDA), but this number would skyrocket to over 125 by ...
The Asilomar Conference on Recombinant DNA was an influential conference organized by Paul Berg, [1] Maxine Singer, [2] and colleagues to discuss the potential biohazards and regulation of biotechnology, held in February 1975 at a conference center at Asilomar State Beach, California. [3]
Verastem Executives Featured at Boston-Area Biotechnology Events CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Verastem, Inc. (NAS: VSTM) , focused on discovering and developing drugs to treat cancer by the ...
Part of a series on Biology Science of life Index Outline Glossary History (timeline) Key components Cell theory Ecosystem Evolution Phylogeny Properties of life Adaptation Energy processing Growth Order Regulation Reproduction Response to environment Domains and Kingdoms of life Archaea Bacteria Eukarya (Animals, Fungi, Plants, Protists) Branches Abiogenesis Aerobiology Agronomy Agrostology ...
The Biotechnology Innovation Organization (BIO) is the largest advocacy association in the world representing the biotechnology industry. [1] [2] [3] It was founded in 1993 as the Biotechnology Industry Organization from a merger of the Industrial Biotechnology Association (IBA) and the Association of Biotechnology Companies (ABC), [4] and changed its name to the Biotechnology Innovation ...
CELEBRATION, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on addressing unmet needs for the treatment of rare diseases, today announced its upcoming addition to the Nasdaq Biotechnology Index (Nasdaq: NBI) (“NBI”) as part of the annual reconstitution of the 2024 Nasdaq indexes.
Research in Computational Molecular Biology (RECOMB) is an annual academic conference on the subjects of bioinformatics and computational biology.The conference has been held every year since 1997 and is widely considered as one of two best international conferences in computational biology publishing rigorously peer-reviewed papers, alongside the ISMB conference.